Abstract:BackgroundClustered regulatory interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)-mediated genome editing permits the rapid production of genetically engineered mice. To make the most of this innovative technology, a streamlined procedure is needed for the robust construction of CRISPR/Cas9 vectors, the efficient preparation of mouse oocytes, and refined genotyping strategies. Although we previously demonstrated the applicability of oocyte cryopreservation technologies and various genotyping methods in the production of transcription activator-like effector nuclease-mediated genome editing in mice, it has not yet been clarified whether these techniques can be applied to the CRISPR/Cas9-mediated generation of knockout mice. In this study, we investigated easy, efficient, and robust methods of creating knockout mice using several CRISPR/Cas9 systems.ResultsWe constructed three types of CRISPR/Cas9 vectors expressing: 1) single guide RNA (gRNA) and Cas9 nuclease, 2) two gRNAs and Cas9 nickase, and 3) two gRNAs and FokI-dCas9, targeting the same genomic locus. These vectors were directly microinjected into the pronucleus of freeze-thawed fertilized oocytes, and surviving oocytes were transferred to pseudopregnant ICR mice. Cas9 nuclease resulted in the highest mutation rates with the lowest birth rates, while Cas9 nickase resulted in the highest birth rates with the lowest mutation rates. FokI-dCas9 presented well-balanced mutation and birth rates. Furthermore, we constructed a single all-in-one FokI-dCas9 vector targeting two different genomic loci, and validated its efficacy by blastocyst analysis, resulting in highly efficient simultaneous targeted mutagenesis.ConclusionsOur report offers several choices of researcher-friendly consolidated procedures for making CRISPR/Cas9-mediated knockout mice, with sophisticated construction systems for various types of CRISPR vectors, convenient preparation of in vitro fertilized or mated freeze-thawed oocytes, and an efficient method of mutant screening.

Ultra-superovulation for the CRISPR-Cas9-mediated production of gene-knockout, single-amino-acid-substituted, and floxed mice

Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes

CRISPR/Cas9-mediated Gene Manipulation to Create Single-Amino-acid-substituted and Floxed Mice with a Cloning-Free Method

Electroporation-mediated genome editing in vitrified/warmed mouse zygotes created by IVF via ultra-superovulation

Rapid generation of conditional knockout mice using the CRISPR-CAS9 system and electroporation for neuroscience research

A non-inheritable maternal Cas9-based multiple-gene editing system in mice

Generation of an Oocyte-Specific Cas9 Transgenic Mouse for Genome Editing.

Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation

CLICK: one-step generation of conditional knockout mice

A Comparison Study of Superovulation Strategies for C57BL/6J and B6D2F1 Mice in CRISPR-Cas9 Mediated Genome Editing.

Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONAD

Efficient generation of conditional knockout mice via sequential introduction of lox sites

Efficient Production of Gene-Modified Mice using Staphylococcus aureus Cas9

A Simple and Efficient Method for Generating KO Rats Using In Vitro Fertilized Oocytes

Feasibility for a large scale mouse mutagenesis by injecting CRISPR/Cas plasmid into zygotes

One-step generation of mice with gene editing by Tol2 transposon-dependent gRNA delivery.

Generation of Floxed Mice by Sequential Electroporation

Electroporation and genetic supply of Cas9 increase the generation efficiency of CRISPR/Cas9 knock-in alleles in C57BL/6J mouse zygotes

Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos

An oocyte‐specific Cas9‐expressing mouse for germline CRISPR/Cas9‐mediated genome editing

Genome editing using type I-E CRISPR-Cas3 in mice and rat zygotes